Sara Sherman | Head, Investor Relations |
Liz Barrett | President and CEO |
Dr. Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Molly Henderson | Chief Financial Officer |
Chris Howerton | Jefferies |
Derek Archila | Stifel |
Hannah Adeoye | J.P. Morgan |
Matt Kaplan | Ladenburg Thalmann |
Paul Choi | Goldman Sachs |
Good morning, ladies and gentlemen. Thank you for standing by. And welcome to the UroGen Pharma’s Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Sara Sherman, Head of Investor Relations at UroGen Pharma. Please go ahead.